(Q54124954)

English

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

lung small cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kalemkerian GP

1

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Jiroutek M

2

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Ettinger DS

3

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Dorighi JA

4

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Johnson DH

5

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Mabry M

6

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

83

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

6

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

1102-1108

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Changes in morphologic and biochemical characteristics of small cell carcinoma of the lung. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Retinoids in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Pathogenesis and management of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980915%2983%3A6%3C1102%3A%3AAID-CNCR8%3E3.0.CO%3B2-9

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 May 2018

http://europepmc.org/abstract/MED/9740074

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54124954&oldid=1584620465"